biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of tauopathies.
TauC3 Biologics Limited has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
TauC3 Biologics Limited's investors include Alzheimer's Association, Rainwater Charitable Foundation.
TauC3 Biologics Limited is headquartered in Holborn, United Kingdom.
biopharmaceutical company focused on the development of innovative immunotherapies for the treatment of tauopathies.
TauC3 Biologics Limited is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TauC3 Biologics Limited — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/tauc3-biologics-limited. Accessed October 30, 2026.
VCBacked. (2025). TauC3 Biologics Limited — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/tauc3-biologics-limited
{{cite web |title=TauC3 Biologics Limited — Funding & Investors |url=https://www.vcbacked.co/company/tauc3-biologics-limited |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated